Our customers say Excellent Rated 4.7 Trustpilot Trustpilot

Quick summary

Type of Medicine

GLP-1 receptor agonist.

Generic

No

Active Ingredient

Orforglipron

Effective Within

4–8 weeks

Works By

Activates GLP-1 receptors in the brain to reduce appetite and increase feelings of fullness, supporting sustained weight loss.

Side Effects

Nausea, constipation, diarrhoea, vomiting, indigestion, abdominal pain, headache, swollen belly, fatigue, belching, heartburn, gas, and hair loss

Wegovy® pen or pill?

Zepbound® KwikPen®
From $299.00
Foundayo Tablets
From $149.00
Zepbound® Pen

Eli Lilly

Zepbound® Pen
$1,245.00
How it’s taken

One weekly shot with one pen a month

One tablet a day

One weekly shot with one pen a week.

Average weight loss

Lose around 20–21% of body weight*

Lose around 11% of body weight*

Lose around 20–21% of body weight*

Best for

People who prefer a weekly routine

People who prefer no needles

People who prefer a weekly routine

How to take it

Inject under the skin using a pre-filled pen. The same pen has 4 doses for 4 weeks.

Take on an empty stomach with water

Inject under the skin using a pre-filled pen.

Payment method

Cash-pay only

Cash-pay only

Cash-pay or insurance might be available

How it works

1. Check eligibility
1. Check eligibility

Answer a short online questionnaire about your health, goals, medical history, and current medications.

2. Clinical review
2. Clinical review

An independent, licensed US physician reviews your consultation and decides whether GLP-1 treatment is appropriate.

3. Prescription if appropriate
3. Prescription if appropriate

If approved, your assigned clinician issues a prescription for the treatment that best fits your needs.

4. Delivery and ongoing support
4. Delivery and ongoing support

Your treatment is delivered discreetly, with ongoing support for dose questions, side effects, and check-ins.

Product details

Description

Foundayo tablets contain orforglipron, a once-daily oral small-molecule GLP-1 receptor agonist developed by Eli Lilly. Unlike peptide-based GLP-1 therapies, orforglipron can be taken at any time of day with no food or water restrictions. Foundayo is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity, or in adults with overweight in the presence of at least one weight-related comorbid condition. 

Directions

Once a day one tablet.

Ingredients

Active Ingredient: Orforglipron. Each tablet contains orforglipron as the active substance. Excipients include microcrystalline cellulose, mannitol, crospovidone, and magnesium stearate.

Side Effects

Gastrointestinal problems (nausea, vomiting, diarrhoea, constipation), abdominal discomfort. Most side effects are mild to moderate and occur during dose escalation.

Warning

When using Foundayo (orforglipron), consult your doctor before use especially if you have a history of pancreatitis, thyroid conditions, or are taking other medications. This medicine is not yet authorised by the EMA for use in the European Union.

FAQs

Can Foundayo be taken at any time of day?

Yes. Unlike other oral GLP-1 medications, Foundayo can be taken at any time of day with no food or water restrictions.

How quickly does Foundayo start to work?

The onset of Foundayo's effects can vary, but patients may begin to notice changes in appetite and weight within the first few weeks of treatment. Full effects are typically seen over 36–72 weeks.

How is Foundayo administered?

Foundayo is taken as a once-daily oral tablet. It can be swallowed whole at any time of day, with or without food and water. Do not crush or chew the tablet.

How should Foundayo be stored?

Store Foundayo at room temperature, below 30°C. Keep out of reach of children. Do not use after the expiry date printed on the packaging.

Do I need a prescription for Foundayo?

Yes. Foundayo is a prescription-only medication. You will need to consult a healthcare provider to determine if Foundayo is appropriate for you before it can be prescribed.

Didn’t find your answer?

Don't hestitate to contact us